Healthcare >> CEO Interviews >> July 24, 2000
PETER RAYMOND is the Chairman and Acting CEO of Tepnel Life Science Plc.
Mr Raymond is a chemist by first degree qualification, an entrepreneur
by business experience and an enthusiast for life, innovation and
venturing. After early "big company" experience with Dow Corning, ICI
and Geigy/CIBA Geigy, Peter founded his first company distributing
speciality chemicals and progressed to full manufacturing of American
products under licence. The experience of being European Director of
Corporate Development for The Dexter Corporation provided the
springboard to becoming the first Managing Director of UMIST (University
of Manchester Institute of Science and Technology) Ventures Ltd. During
his time at UMIST, 20 high tech "Newcos" were founded, all with private
capital over a six year period, one of which was Tepnel. Mr Raymond
became Chairman of Tepnel in 1998 and acting CEO in 1999. He believes
that Tepnel can become a world player in the supply of DNA-driven
enabling technologies, services and test kits, following the
commercialisation of its automated DNA purification technology.
Tepnel's market, the global DNA market, will expand further following
the successful outcome of the Human Genome Project. With a portfolio of
patented DNA technologies, service laboratories and kit based products,
Tepnel will realise it's full potential through partnerships and
distribution agreements. Mr Raymond is married with four children and
has three grandchildren. Profile
Tepnel Life Sciences?
Mr. Raymond: Tepnel is a spin-off from the University of Manchester
Institute of Science and
